A citation-based method for searching scientific literature

C Dodson, T J Richards, D A Smith, N H Ramaiya. AJNR Am J Neuroradiol 2020
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brain metastasis from non-small cell lung cancer (NSCLC): prognostic importance of the number of involved extracranial organs.
L Gerdan, B Segedin, V Nagy, M T Khoa, N T Trang, S E Schild, D Rades. Strahlenther Onkol 2014
18
100

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Paul W Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K Sneed, Samuel T Chao, Robert J Weil, John Suh,[...]. J Clin Oncol 2012
894
100

Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience.
Ryan T Hughes, Adrianna H Masters, Emory R McTyre, Michael K Farris, Caroline Chung, Brandi R Page, Lawrence R Kleinberg, Jaroslaw Hepel, Joseph N Contessa, Veronica Chiang,[...]. Int J Radiat Oncol Biol Phys 2019
50
50

Efficacy of nano-particulated, water-soluble erlotinib against intracranial metastases of EGFR-mutant lung cancer.
Dong Ha Kim, Yun Jung Choi, Ki Jung Sung, Seon-A Yoo, Young Hoon Sung, Jeong Kon Kim, Chang-Min Choi, Miyong Yun, Eun Yong Lee, Yong Suk Jin,[...]. Mol Oncol 2018
6
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC).
Cyrille B Confavreux, Nicolas Girard, Jean-Baptiste Pialat, Pierre-Paul Bringuier, Mojgan Devouassoux-Shisheboran, Jean-Charles Rousseau, Sylvie Isaac, Françoise Thivolet-Bejui, Philippe Clezardin, Marie Brevet. Bonekey Rep 2014
20
50

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Metellus, L'Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Frederic Fina, Celine Mascaux,[...]. Int J Mol Sci 2016
33
50

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
L Gaspar, C Scott, M Rotman, S Asbell, T Phillips, T Wasserman, W G McKenna, R Byhardt. Int J Radiat Oncol Biol Phys 1997
50

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.
Arik Bernard Schulze, Georg Evers, Andrea Kerkhoff, Michael Mohr, Christoph Schliemann, Wolfgang E Berdel, Lars Henning Schmidt. Cancers (Basel) 2019
41
50


LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation.
Dianne Hartgerink, Ans Swinnen, David Roberge, Alan Nichol, Piotr Zygmanski, Fang-Fang Yin, François Deblois, Coen Hurkmans, Chin Loon Ong, Anna Bruynzeel,[...]. Acta Oncol 2019
26
50

Brain metastases in non-small-cell lung cancer.
David E Dawe, Jeffrey N Greenspoon, Peter M Ellis. Clin Lung Cancer 2014
27
50

Targeting MET amplification in EGFR-mutant non-small-cell lung cancer.
Rafael Rosell, Imane Chaib, Mariacarmela Santarpia. Lancet Respir Med 2020
8
50

The number of involved extracranial organs: a new predictor of survival in breast cancer patients with brain metastasis.
Lavinia Gerdan, Barbara Segedin, Viorica Nagy, Mai T Khoa, Ngo T Trang, Steven E Schild, Dirk Rades. Clin Neurol Neurosurg 2013
6
50

Brain metastases.
Achal Singh Achrol, Robert C Rennert, Carey Anders, Riccardo Soffietti, Manmeet S Ahluwalia, Lakshmi Nayak, Solange Peters, Nils D Arvold, Griffith R Harsh, Patricia S Steeg,[...]. Nat Rev Dis Primers 2019
297
50

Systemic treatment of brain metastases in non-small cell lung cancer.
Simon Page, Charlotte Milner-Watts, Marco Perna, Urska Janzic, Natalia Vidal, Naila Kaudeer, Merina Ahmed, Fiona McDonald, Imogen Locke, Anna Minchom,[...]. Eur J Cancer 2020
28
50

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
Daniel R Gomez, Chad Tang, Jianjun Zhang, George R Blumenschein, Mike Hernandez, J Jack Lee, Rong Ye, David A Palma, Alexander V Louie, D Ross Camidge,[...]. J Clin Oncol 2019
508
50

Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers.
Aaron C Tan, Malinda Itchins, Mustafa Khasraw. Int J Mol Sci 2020
8
50

Lung cancer surgery in oligometastatic patients: outcome and survival.
Monica Casiraghi, Luca Bertolaccini, Giulia Sedda, Francesco Petrella, Domenico Galetta, Juliana Guarize, Patrick Maisonneuve, Filippo De Marinis, Lorenzo Spaggiari. Eur J Cardiothorac Surg 2020
19
50

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, Hubert Pan, Paul D Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E Gaspar, Steve Braunstein,[...]. JAMA Oncol 2017
342
50

Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis.
Daniel Breadner, Phillip Blanchette, Sumugan Shanmuganathan, Ronald Gabriel Boldt, Jacques Raphael. Lung Cancer 2020
13
50

Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.
Alison Dormieux, Laura Mezquita, Paul Henry Cournede, Jordi Remon, Melodie Tazdait, Ludovic Lacroix, Etienne Rouleau, Julien Adam, Maria-Virginia Bluthgen, Francesco Facchinetti,[...]. Eur Radiol 2020
6
50

Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies.
Jonathan Khalifa, Arya Amini, Sanjay Popat, Laurie E Gaspar, Corinne Faivre-Finn. J Thorac Oncol 2016
53
50

Prognostic value of site-specific metastases in lung cancer: A population based study.
Jing Li, Huaguang Zhu, Lei Sun, Wenqian Xu, Xin Wang. J Cancer 2019
29
50

FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
Giustina Ferone, Ji-Ying Song, Oscar Krijgsman, Jan van der Vliet, Miranda Cozijnsen, Ekaterina A Semenova, David J Adams, Daniel Peeper, Anton Berns. Cell Rep 2020
14
50

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Julian R Molina, Ping Yang, Stephen D Cassivi, Steven E Schild, Alex A Adjei. Mayo Clin Proc 2008
50



Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.
Chiara D'Antonio, Antonio Passaro, Bruno Gori, Ester Del Signore, Maria Rita Migliorino, Serena Ricciardi, Alberto Fulvi, Filippo de Marinis. Ther Adv Med Oncol 2014
131
50

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer.
Jiyeon Yun, Min Hee Hong, Seok-Young Kim, Chae-Won Park, Soyoung Kim, Mi Ran Yun, Han Na Kang, Kyoung-Ho Pyo, Sung Sook Lee, Jong Sung Koh,[...]. Clin Cancer Res 2019
37
50

Specific organ metastases and survival in metastatic non-small-cell lung cancer.
Tomohiro Tamura, Koichi Kurishima, Kensuke Nakazawa, Katsunori Kagohashi, Hiroichi Ishikawa, Hiroaki Satoh, Nobuyuki Hizawa. Mol Clin Oncol 2015
138
50

Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.
Steven H J Nagtegaal, An Claes, Karijn P M Suijkerbuijk, Franz M N H Schramel, Tom J Snijders, Joost J C Verhoeff. Radiother Oncol 2019
12
50

Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer.
Lina Li, Shuimei Luo, Heng Lin, Haitao Yang, Huijuan Chen, Ziyuan Liao, Wanzun Lin, Weili Zheng, Xianhe Xie. J Thorac Dis 2017
44
50

Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non‒Small-Cell Lung Cancer in Routine Clinical Practice.
Chang Liu, Hui Yu, Jianhua Chang, Haiquan Chen, Yuan Li, Weixin Zhao, Kuaile Zhao, Zhengfei Zhu, Si Sun, Min Fan,[...]. Target Oncol 2019
14
50

Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-Small Cell Lung Cancer.
Ziming Li, Lan Shen, Ding Ding, Jia Huang, Jie Zhang, Zhiwei Chen, Shun Lu. J Thorac Oncol 2018
45
50

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
50


Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?
J Remon, L E Hendriks, C Cabrera, N Reguart, B Besse. Cancer Treat Rev 2018
32
50

Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
Amanda Jane Williams Gibson, Haocheng Li, Adrijana D'Silva, Roxana A Tudor, Anifat A Elegbede, Shannon Mary Otsuka, D Gwyn Bebb, Winson Y Cheung. Med Oncol 2018
27
50

Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study.
David Waterhouse, Laura Iadeluca, Sneha Sura, Keith Wilner, Birol Emir, Stan Krulewicz, Janet Espirito, Lauren Bartolome. Target Oncol 2022
2
50

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer.
K Takezawa, I Okamoto, W Okamoto, M Takeda, K Sakai, S Tsukioka, K Kuwata, H Yamaguchi, K Nishio, K Nakagawa. Br J Cancer 2011
135
50

Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer.
Sandra D Griffith, Melisa Tucker, Bryan Bowser, Geoffrey Calkins, Che-Hsu Joe Chang, Ellie Guardino, Sean Khozin, Josh Kraut, Paul You, Deb Schrag,[...]. Adv Ther 2019
69
50

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.
Stefan Zimmermann, Rafal Dziadziuszko, Solange Peters. Cancer Treat Rev 2014
87
50

An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor-Refractory ALK-Positive or ROS1-Positive NSCLC.
Viola W Zhu, Yen-Ting Lin, Dong-Wan Kim, Herbert H Loong, Misako Nagasaka, Hao To, Yvonne Li-En Ang, Chan-Young Ock, Nishan Tchekmedyian, Sai-Hong Ignatius Ou,[...]. J Thorac Oncol 2020
27
50

The REDCap consortium: Building an international community of software platform partners.
Paul A Harris, Robert Taylor, Brenda L Minor, Veida Elliott, Michelle Fernandez, Lindsay O'Neal, Laura McLeod, Giovanni Delacqua, Francesco Delacqua, Jacqueline Kirby,[...]. J Biomed Inform 2019
50

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
Julien Mazières, Gérard Zalcman, Lucio Crinò, Pamela Biondani, Fabrice Barlesi, Thomas Filleron, Anne-Marie C Dingemans, Hervé Léna, Isabelle Monnet, Sacha I Rothschild,[...]. J Clin Oncol 2015
248
50

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer.
Justin F Gainor, Diane Tseng, Satoshi Yoda, Ibiayi Dagogo-Jack, Luc Friboulet, Jessica J Lin, Harper G Hubbeling, Leila Dardaei, Anna F Farago, Katherine R Schultz,[...]. JCO Precis Oncol 2017
145
50

Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.
D G Bebb, J Agulnik, R Albadine, S Banerji, G Bigras, C Butts, C Couture, J C Cutz, P Desmeules, D N Ionescu,[...]. Curr Oncol 2019
6
50

Expanding the Roster of ROS1 Inhibitors.
Ibiayi Dagogo-Jack, Alice T Shaw. J Clin Oncol 2017
11
50

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
Ryohei Katayama, Alice T Shaw, Tahsin M Khan, Mari Mino-Kenudson, Benjamin J Solomon, Balazs Halmos, Nicholas A Jessop, John C Wain, Alan Tien Yeo, Cyril Benes,[...]. Sci Transl Med 2012
926
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.